Carboxymethyl kappa-carrageenan polyelectrolyte multilayers: anticoagulant blood-compatible coatings as sustainable alternatives to heparin for blood- contacting surfaces

preprint OA: closed
Full text JSON View at publisher

Abstract

Abstract This research introduces carboxymethyl kappa-carrageenan-chitosan polyelectrolyte multilayers as a promising and sustainable alternative to heparin, used in surface treatments for blood-contacting medical devices. The polysaccharide-based surface coatings have good cytocompatibility and resist microbial adhesion of both Pseudomonas aeruginosa and Staphylococcus aureus. The blood compatibility of surfaces containing carboxymethyl-kappa-carrageenan was directly compared to similar polyelectrolyte multilayers containing heparin. The carboxymethyl-kappa-carrageenan surfaces inhibit whole-blood clotting like heparin-containing surfaces. Blood clotting is mediated by both protein-surface and cell-surface interactions. The carboxymethyl-kappa-carrageenan surfaces adsorb more fibrinogen and less albumin than the heparin surfaces, and they also exhibit reduced platelet and leukocyte adhesion, compared to heparin surfaces. These results suggest that carboxymethyl-kappa-carrageenan may represent a sustainable alternative to heparin as an anticoagulant surface modification.
Full text 13,174 characters · extracted from preprint-html · click to expand
Carboxymethyl kappa-carrageenan polyelectrolyte multilayers: anticoagulant blood-compatible coatings as sustainable alternatives to heparin for blood- contacting surfaces | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Carboxymethyl kappa-carrageenan polyelectrolyte multilayers: anticoagulant blood-compatible coatings as sustainable alternatives to heparin for blood- contacting surfaces Liszt Y. C. Madruga, Somayeh Baghersad, Paulo C.F. Câmara, Roberta M. Sabino, and 2 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-7014360/v1 This work is licensed under a CC BY 4.0 License Status: Under Review Version 1 posted 10 You are reading this latest preprint version Abstract This research introduces carboxymethyl kappa-carrageenan-chitosan polyelectrolyte multilayers as a promising and sustainable alternative to heparin, used in surface treatments for blood-contacting medical devices. The polysaccharide-based surface coatings have good cytocompatibility and resist microbial adhesion of both Pseudomonas aeruginosa and Staphylococcus aureus. The blood compatibility of surfaces containing carboxymethyl-kappa-carrageenan was directly compared to similar polyelectrolyte multilayers containing heparin. The carboxymethyl-kappa-carrageenan surfaces inhibit whole-blood clotting like heparin-containing surfaces. Blood clotting is mediated by both protein-surface and cell-surface interactions. The carboxymethyl-kappa-carrageenan surfaces adsorb more fibrinogen and less albumin than the heparin surfaces, and they also exhibit reduced platelet and leukocyte adhesion, compared to heparin surfaces. These results suggest that carboxymethyl-kappa-carrageenan may represent a sustainable alternative to heparin as an anticoagulant surface modification. Full Text Additional Declarations No competing interests reported. Supplementary Files SupInfo7.06.25LM.docx Cite Share Download PDF Status: Under Review Version 1 posted Editorial decision: Revision requested 29 Sep, 2025 Reviews received at journal 22 Sep, 2025 Reviewers agreed at journal 12 Sep, 2025 Reviews received at journal 30 Aug, 2025 Reviewers agreed at journal 21 Aug, 2025 Reviewers agreed at journal 14 Aug, 2025 Reviewers invited by journal 04 Aug, 2025 Editor assigned by journal 01 Aug, 2025 Submission checks completed at journal 28 Jul, 2025 First submitted to journal 28 Jul, 2025 You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-7014360","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":495474451,"identity":"ce6c8713-5957-47df-a052-5579d0626879","order_by":0,"name":"Liszt Y. C. Madruga","email":"","orcid":"","institution":"Colorado State University","correspondingAuthor":false,"prefix":"","firstName":"Liszt","middleName":"Y. C.","lastName":"Madruga","suffix":""},{"id":495474452,"identity":"d47e495e-a3e5-47f8-97e1-b54cf0785e32","order_by":1,"name":"Somayeh Baghersad","email":"","orcid":"","institution":"Colorado State University","correspondingAuthor":false,"prefix":"","firstName":"Somayeh","middleName":"","lastName":"Baghersad","suffix":""},{"id":495474453,"identity":"8c654f68-182b-4777-ad26-5f4641f09b47","order_by":2,"name":"Paulo C.F. Câmara","email":"","orcid":"","institution":"Federal University of Rio Grande do Norte, UFRN","correspondingAuthor":false,"prefix":"","firstName":"Paulo","middleName":"C.F.","lastName":"Câmara","suffix":""},{"id":495474454,"identity":"ecbd6549-3533-49f2-bcac-0501dfcaa159","order_by":3,"name":"Roberta M. Sabino","email":"","orcid":"","institution":"University of Wyoming","correspondingAuthor":false,"prefix":"","firstName":"Roberta","middleName":"M.","lastName":"Sabino","suffix":""},{"id":495474455,"identity":"87eb838f-0696-41c0-88a4-e9c3e87eb98c","order_by":4,"name":"Matt J. Kipper","email":"","orcid":"","institution":"Colorado State University","correspondingAuthor":false,"prefix":"","firstName":"Matt","middleName":"J.","lastName":"Kipper","suffix":""},{"id":495474456,"identity":"54f12575-f671-4be3-93be-775053125e1e","order_by":5,"name":"Ketul C. Popat","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAAr0lEQVRIiWNgGAWjYBACCQhlA6F4iNeSkEa6lsMkaJGc3Xzswc8f5+3WzkhgfPC2jQgt0jLH0g17Em4nb7uRwGw4lxgtchI5ZhI8QC1mNxLYpHmJ1SL5J+EcSAv7b6K0SAO1SPMkHLAD2cJMlBbJOcfSjWXSkhPMzjxslpxzjggtErebjz18Y2Nnb3Y8+eCHN2VEaAFGDBuISmxgYGwgRj1Ciz2RykfBKBgFo2AkAgDRdDVgsXsfCAAAAABJRU5ErkJggg==","orcid":"","institution":"Colorado State University","correspondingAuthor":true,"prefix":"","firstName":"Ketul","middleName":"C.","lastName":"Popat","suffix":""}],"badges":[],"createdAt":"2025-06-30 22:23:05","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-7014360/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-7014360/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":88472771,"identity":"5e8231e3-2626-4253-8f1f-4ede72aea091","added_by":"auto","created_at":"2025-08-06 19:48:49","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":1283788,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript7.28.25LM.pdf","url":"https://assets-eu.researchsquare.com/files/rs-7014360/v1_covered_94044228-0d8f-4dd8-8493-5b42c5db71e9.pdf"},{"id":88471751,"identity":"17422339-06de-4bd3-9815-b2d6b4f0df32","added_by":"auto","created_at":"2025-08-06 19:16:44","extension":"docx","order_by":0,"title":"","display":"","copyAsset":false,"role":"supplement","size":2823777,"visible":true,"origin":"","legend":"","description":"","filename":"SupInfo7.06.25LM.docx","url":"https://assets-eu.researchsquare.com/files/rs-7014360/v1/5efac1d434c8d9f7e5e507d3.docx"}],"financialInterests":"No competing interests reported.","formattedTitle":"Carboxymethyl kappa-carrageenan polyelectrolyte multilayers: anticoagulant blood-compatible coatings as sustainable alternatives to heparin for blood- contacting surfaces","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":true,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"discover-biotechnology","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"","sideBox":"Learn more about [Discover Biotechnology](https://link.springer.com/journal/44340)","snPcode":"44340","submissionUrl":"https://submission.springernature.com/new-submission/44340/3","title":"Discover Biotechnology","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"stoa","reportingPortfolio":"Discover Series","inReviewEnabled":true,"inReviewRevisionsEnabled":true},"keywords":"","lastPublishedDoi":"10.21203/rs.3.rs-7014360/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-7014360/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003eThis research introduces carboxymethyl kappa-carrageenan-chitosan polyelectrolyte multilayers as a promising and sustainable alternative to heparin, used in surface treatments for blood-contacting medical devices. The polysaccharide-based surface coatings have good cytocompatibility and resist microbial adhesion of both Pseudomonas aeruginosa and Staphylococcus aureus. The blood compatibility of surfaces containing carboxymethyl-kappa-carrageenan was directly compared to similar polyelectrolyte multilayers containing heparin. The carboxymethyl-kappa-carrageenan surfaces inhibit whole-blood clotting like heparin-containing surfaces. Blood clotting is mediated by both protein-surface and cell-surface interactions. The carboxymethyl-kappa-carrageenan surfaces adsorb more fibrinogen and less albumin than the heparin surfaces, and they also exhibit reduced platelet and leukocyte adhesion, compared to heparin surfaces. These results suggest that carboxymethyl-kappa-carrageenan may represent a sustainable alternative to heparin as an anticoagulant surface modification.\u003c/p\u003e","manuscriptTitle":"Carboxymethyl kappa-carrageenan polyelectrolyte multilayers: anticoagulant blood-compatible coatings as sustainable alternatives to heparin for blood- contacting surfaces","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2025-08-06 19:16:39","doi":"10.21203/rs.3.rs-7014360/v1","editorialEvents":[{"type":"communityComments","content":0},{"type":"decision","content":"Revision requested","date":"2025-09-29T11:16:04+00:00","index":"","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2025-09-22T08:54:04+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"29669134585028992863924302237101952858","date":"2025-09-12T12:14:21+00:00","index":"hide","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2025-08-30T10:53:17+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"131199566547163533548349235828575709815","date":"2025-08-21T06:15:24+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"283640549905227439606157000250611369969","date":"2025-08-14T10:11:54+00:00","index":"hide","fulltext":""},{"type":"reviewersInvited","content":"","date":"2025-08-04T14:26:36+00:00","index":"","fulltext":""},{"type":"editorAssigned","content":"","date":"2025-08-01T05:30:50+00:00","index":"","fulltext":""},{"type":"checksComplete","content":"","date":"2025-07-28T16:00:42+00:00","index":"","fulltext":""},{"type":"submitted","content":"Discover Biotechnology","date":"2025-07-28T15:56:30+00:00","index":"","fulltext":""}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"discover-biotechnology","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"","sideBox":"Learn more about [Discover Biotechnology](https://link.springer.com/journal/44340)","snPcode":"44340","submissionUrl":"https://submission.springernature.com/new-submission/44340/3","title":"Discover Biotechnology","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"stoa","reportingPortfolio":"Discover Series","inReviewEnabled":true,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"f58caaab-562e-4176-aabe-9ab3afa5ff4a","owner":[],"postedDate":"August 6th, 2025","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"under-review","subjectAreas":[],"tags":[],"updatedAt":"2025-11-04T05:53:16+00:00","versionOfRecord":[],"versionCreatedAt":"2025-08-06 19:16:39","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-7014360","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-7014360","identity":"rs-7014360","version":["v1"]},"buildId":"8U1c8b4HqxoKbykW_rLl7","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00